Veracyte
VCYT
55 hedge funds and large institutions have $82.9M invested in Veracyte in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 18 increasing their positions, 14 reducing their positions, and 13 closing their positions.
29% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 14
0.41% more ownership
Funds ownership: 54.73% → 55.14% (+0.41%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less capital inflows, than outflows
Capital inflows: $8.85M | Capital outflows: $8.93M
14% less funds holding
Funds holding: 64 → 55 (-9)
69% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 13
93% less call options, than puts
Call options by funds: $135K | Put options by funds: $1.87M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$6.04M |
| 2 |
Bridgeway Capital Management
Houston,
Texas
|
+$636K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
+$331K |
| 4 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
+$324K |
| 5 |
State Street
Boston,
Massachusetts
|
+$255K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Driehaus Capital Management
Chicago,
Illinois
|
-$2.03M |
| 2 |
Deerfield Management
New York
|
-$1.34M |
| 3 |
Broadfin Capital
New York
|
-$1.23M |
| 4 |
Clough Capital Partners
Boston,
Massachusetts
|
-$852K |
| 5 |
Millennium Management
New York
|
-$849K |
VCYT Hedge Fund Activity: Q1 2016 in Review
55 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q1 2016, worth a combined $82.9M — down 24% from $110M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of VCYT and 4 opened new positions — a net loss of 9 holders — while 14 trimmed existing stakes and 18 added.
The largest buyer was Acuta Capital Partners, adding an estimated $6.04M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $2.03M sold.
- 55 institutional investors held Veracyte (VCYT) as of Q1 2016, down from 64 in Q4 2015.
- Funds reported $82.9M of Veracyte stock for Q1 2016, down 24% quarter-over-quarter.
- 4 funds opened new Veracyte positions in Q1 2016 and 13 closed out, a net change of -9 holders.
- The largest Veracyte buyer in Q1 2016 was Acuta Capital Partners, an estimated $6.04M added.
- The largest Veracyte seller in Q1 2016 was Driehaus Capital Management, an estimated $2.03M sold.
Based on aggregated 13F filings for Q1 2016.